home / stock / pki / pki news


PKI News and Press, PerkinElmer Inc. From 07/05/21

Stock Information

Company Name: PerkinElmer Inc.
Stock Symbol: PKI
Market: NYSE
Website: perkinelmer.com

Menu

PKI PKI Quote PKI Short PKI News PKI Articles PKI Message Board
Get PKI Alerts

News, Short Squeeze, Breakout and More Instantly...

PKI - Perkinelmer PKI Technical Data

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

PKI - NIH study suggests antigen tests and PCR tests are equally effective in detecting COVID-19

Hoptocopter/E+ via Getty Images Citing a peer-reviewed study published in the Journal of Infectious Diseases, the National Institute of Health says that both rapid antigen tests and PCR molecular tests have a high rate of sensitivity in detecting COVID-19. The PCR tests, considered the g...

PKI - PerkinElmer on track to snap winning streak on lower-than-expected guidance

TheCrimsonRibbon/iStock via Getty Images PerkinElmer ([[PKI]] -1.8%) is set to record its first intra-day loss in more than two weeks after the company’s 2023 guidance came below expectations. On its Virtual Investor and Analyst Day, PerkinElmer projected 2023 adjusted earnings per sha...

PKI - PerkinElmer foresees 2Q21 earnings to be above the prior guidance

PerkinElmer (PKI) expects to beat prior Q2 guidance of $2.35 and $1.11 billion in revenue vs. a consensus EPS of $2.44 and $1.12 billion in revenue.PerkinElmer will release its Q2 financial results after market close on Wednesday, July 28, 2021.Prior outlook. For further details see: Pe...

PKI - PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021

Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day th...

PKI - PerkinElmer to acquire viral vector gene delivery company, SIRION Biotech

PerkinElmer (PKI) to acquire privately held SIRION Biotech GmbH, a global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies.The acquisition is expected to close during Q3 2021. SIRION has established a strong licensing portfo...

PKI - PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech

Solutions to complement Company’s growing position in cell and gene therapy research and development PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH , a lead...

PKI - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

PKI - IHF: Healthcare Dashboard For June

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IHF. A list of cheap stocks. For further details see: IHF: Healthcare Dashboard For June

PKI - Why PerkinElmer Is A SWAN Stock You Can Buy Today

PerkinElmer is a healthcare solutions company with a long-track record of market beating returns. It's benefitted from COVID-19 testing, and is exploring promising new growth avenues. I highlight what makes the stock a Buy, along with the balance sheet, and other points worth cons...

Previous 10 Next 10